We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$342B
AUM Growth
+$4.99B
Cap. Flow
-$5.86B
Cap. Flow %
-1.71%
Top 10 Hldgs %
31.71%
Holding
3,487
New
211
Increased
1,344
Reduced
1,316
Closed
159

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.03B
2
VLO icon
Valero Energy
VLO
+$273M
3
PGR icon
Progressive
PGR
+$259M
4
AMD icon
Advanced Micro Devices
AMD
+$256M
5
ORLY icon
O'Reilly Automotive
ORLY
+$232M

Sector Composition

Rank Sector Weight
1 Technology 31.78%
2 Financials 11.71%
3 Healthcare 11.09%
4 Consumer Discretionary 10.64%
5 Communication Services 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORN icon
2151
Orion Group Holdings
ORN
$418M
$3.02M ﹤0.01%
+318,045
New +$2.81M
XERS icon
2152
Xeris Biopharma Holdings
XERS
$1.45B
$3.02M ﹤0.01%
1,342,612
-247,890
-16% -$500K
STEL
2153
DELISTED
Stellar Bancorp
STEL
$3.02M ﹤0.01%
131,530
+3,097
+2% +$70.3K
SHLS icon
2154
Shoals Technologies Group
SHLS
$1.5B
$3.02M ﹤0.01%
483,887
+25,309
+6% +$202K
ACIC icon
2155
American Coastal Insurance
ACIC
$493M
$3.01M ﹤0.01%
284,905
-169,481
-37% -$1.91M
IRWD icon
2156
Ironwood Pharmaceuticals
IRWD
$714M
$3M ﹤0.01%
459,441
-1,383,802
-75% -$9.79M
AORT icon
2157
Artivion
AORT
$1.32B
$2.99M ﹤0.01%
116,517
-68,180
-37% -$1.53M
ELVN icon
2158
Enliven Therapeutics
ELVN
$4.43B
$2.98M ﹤0.01%
127,518
+44,523
+54% +$937K
VNDA icon
2159
Vanda Pharmaceuticals
VNDA
$302M
$2.98M ﹤0.01%
526,823
+224,173
+74% +$1.16M
SHEN icon
2160
Shenandoah Telecom
SHEN
$746M
$2.97M ﹤0.01%
181,658
+50,152
+38% +$808K
NG icon
2161
NovaGold Resources
NG
$3.33B
$2.95M ﹤0.01%
851,424
+4,304
+0.5% +$14.3K
AGX icon
2162
Argan
AGX
$8.37B
$2.95M ﹤0.01%
40,330
MNRO icon
2163
Monro
MNRO
$398M
$2.95M ﹤0.01%
123,508
+23,651
+24% +$631K
HNRG icon
2164
Hallador Energy
HNRG
$696M
$2.93M ﹤0.01%
377,239
+257,600
+215% +$1.61M
SRCE icon
2165
1st Source
SRCE
$2.12B
$2.93M ﹤0.01%
54,639
+9,202
+20% +$466K
UTZ icon
2166
Utz Brands
UTZ
$1.25B
$2.92M ﹤0.01%
175,444
MBUU icon
2167
Malibu Boats
MBUU
$567M
$2.91M ﹤0.01%
83,160
+25,164
+43% +$920K
RLAY icon
2168
Relay Therapeutics
RLAY
$4.33B
$2.91M ﹤0.01%
446,808
+184,925
+71% +$1.26M
SDGR icon
2169
Schrodinger
SDGR
$1.36B
$2.91M ﹤0.01%
150,576
+25
+0% +$576
TBPH icon
2170
Theravance Biopharma
TBPH
$877M
$2.91M ﹤0.01%
342,715
+182,897
+114% +$1.65M
THR
2171
DELISTED
Thermon Group Holdings
THR
$2.9M ﹤0.01%
94,222
HLF icon
2172
Herbalife
HLF
$1.29B
$2.89M ﹤0.01%
277,742
SOUN icon
2173
SoundHound AI
SOUN
$3.49B
$2.88M ﹤0.01%
730,310
+349,315
+92% +$1.62M
COLL icon
2174
Collegium Pharmaceutical
COLL
$956M
$2.88M ﹤0.01%
89,566
+796
+0.9% +$27.6K
SPNT icon
2175
SiriusPoint
SPNT
$2.68B
$2.88M ﹤0.01%
235,834
+48,198
+26% +$601K

Similar funds

Nuveen's Q2 2024 Portfolio in Review

As of Q2 2024, Nuveen held 3,487 positions worth $342B, up 1.5% from $337B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Nuveen's Q2 2024 filing shows 211 new, 1,344 increased, 1,316 reduced and 159 closed positions. Its largest new stake was GE Vernova: 595,802 shares worth $102M. The largest sale was Meta Platforms (Facebook), an estimated $466M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q2 2024 buy was GE Vernova: 595,802 shares worth $102M.
  • Nuveen added most to Apple in Q2 2024, an estimated $1.03B increase.
  • Nuveen's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $466M.
  • Nuveen fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $389M.
  • Nuveen's ten largest holdings make up 32% of its $342B portfolio in Q2 2024.
  • Nuveen opened 211 new positions and closed 159 in Q2 2024.
  • Nuveen's portfolio value rose 1.5% quarter-over-quarter to $342B.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.